Gland Pharma Limited (GLAND.NS)
INR 1764.95
(0.06%)
INR 1764.95
(0.06%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 19.37 Billion INR | 136.61% |
| 2022 | 8.18 Billion INR | 21.13% |
| 2021 | 6.76 Billion INR | 14.03% |
| 2020 | 5.92 Billion INR | 34.8% |
| 2019 | 4.39 Billion INR | -33.52% |
| 2018 | 6.61 Billion INR | 27.44% |
| 2017 | 5.19 Billion INR | 35.21% |
| 2016 | 3.83 Billion INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | -87.23 Billion INR | -550.29% |
| 2024 Q2 | 20.78 Billion INR | 123.83% |
| 2023 Q3 | - INR | -100.0% |
| 2023 FY | 19.37 Billion INR | 136.61% |
| 2023 Q2 | 19.86 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q4 | 19.37 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q2 | 9.7 Billion INR | 0.0% |
| 2022 Q4 | 8.18 Billion INR | 0.0% |
| 2022 FY | 8.18 Billion INR | 21.13% |
| 2022 Q3 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 6.76 Billion INR | 14.03% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q2 | 8.01 Billion INR | 0.0% |
| 2021 Q4 | 6.76 Billion INR | 0.0% |
| 2020 Q4 | 5.92 Billion INR | 0.0% |
| 2020 Q1 | 7.27 Billion INR | 65.48% |
| 2020 FY | 5.92 Billion INR | 34.8% |
| 2019 FY | 4.39 Billion INR | -33.52% |
| 2019 Q4 | 4.39 Billion INR | 0.0% |
| 2019 Q1 | - INR | 0.0% |
| 2018 FY | 6.61 Billion INR | 27.44% |
| 2017 FY | 5.19 Billion INR | 35.21% |
| 2016 FY | 3.83 Billion INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Abbott India Limited | 14.94 Billion INR | -29.627% |
| Cipla Limited | 59.15 Billion INR | 67.249% |
| GlaxoSmithKline Pharmaceuticals Limited | 17.96 Billion INR | -7.866% |
| Kopran Limited | 2.52 Billion INR | -668.807% |
| Marksans Pharma Limited | 5.95 Billion INR | -225.588% |
| NGL Fine-Chem Limited | 929.03 Million INR | -1985.384% |
| Pfizer Limited | 6.33 Billion INR | -205.951% |
| Sanofi India Limited | 6.99 Billion INR | -176.93% |
| SMS Pharmaceuticals Limited | 4.97 Billion INR | -289.221% |
| TTK Healthcare Limited | 1.99 Billion INR | -870.274% |